A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Early Stage Breast Cancer
Interventions: DRUG: Neupogen
Sponsor: Ottawa Hospital Research Institute